Cancer News

As the American Society of Clinical Oncology (ASCO) convenes in Chicago from May 29 to June 2, 2026, the Dana-Farber Cancer Institute is set to showcase groundbreaking research that could transform...

As the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) approaches, researchers from the Dana-Farber Cancer Institute are set to present significant findings that could...

Researchers from Penn Medicine are set to present groundbreaking findings at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, showcasing innovative approaches in cancer...

At the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting set to take place from May 29 to June 2, Penn Medicine will present a series of innovative studies that could reshape the...

Recent findings presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting shed light on the genetic underpinnings of solitary fibrous tumors (SFTs), a rare type of sarcoma....

Recent research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting sheds light on solitary fibrous tumors (SFTs), a rare form of sarcoma. Scientists from Sylvester...

At the upcoming Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place from May 29 to June 3, 2026, experts from Fred Hutch Cancer Center will showcase groundbreaking...

The recent Annual Meeting of the American Society of Clinical Oncology (ASCO) showcased pivotal advancements in cancer research from Fred Hutch Cancer Center, particularly focusing on Merkel cell...

Recent advancements in artificial intelligence (AI) are paving the way for more personalized treatment options for patients diagnosed with multiple myeloma, a complex blood cancer that primarily...

Recent advancements in artificial intelligence (AI) are paving the way for more tailored treatment strategies for patients diagnosed with multiple myeloma, a blood cancer that originates in the bone...

The upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting promises to showcase significant advancements in cancer research, with a strong focus on innovative treatment approaches....

As the field of oncology continues to evolve, significant advancements are being made in cancer research. At the upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, researchers...

As the American Society of Clinical Oncology (ASCO) Annual Meeting approaches, researchers from Rutgers Cancer Institute and RWJBarnabas Health are set to unveil groundbreaking findings that could...

As the landscape of cancer treatment continues to evolve, researchers from Rutgers Cancer Institute and RWJBarnabas Health are set to present groundbreaking findings at the highly anticipated 2026...

Recent developments in breast cancer legislation have sparked optimism among advocates and healthcare professionals. The U.S. House Energy and Commerce Committee has moved forward with two crucial...

Recent research from The University of Texas MD Anderson Cancer Center and Weill Cornell Medicine has shed light on the mechanisms behind resistance to KRAS inhibitors in colorectal cancer. This...

Recent research from The University of Texas MD Anderson Cancer Center and Weill Cornell Medicine has shed light on the complex mechanisms that enable colorectal cancer cells to resist KRAS...

In a significant development for pancreatic cancer treatment, a clinical trial has commenced in the United States to evaluate the efficacy of focused ultrasound technology. The SUNRISE-II trial,...

In a significant move aimed at enhancing the accuracy of cancer treatment evaluations, dermatologists and oncologists from the Icahn School of Medicine at Mount Sinai are calling for a comprehensive...

Recent advancements in cancer research have unveiled a significant breakthrough in the diagnosis and treatment of rare but aggressive forms of brain and eye cancers. A study published in the Clinical...